The IonQ-SkyWater merger has raised a question that extends well beyond the transaction itself, forcing regulators to confront competing priorities.
At issue is what happens when national security considerations and competition concerns pull agencies in fundamentally opposite directions during merger review.
The tension arrives as US officials grow increasingly worried about the defence industrial base’s capacity to sustain prolonged conflict and replenish weapons stockpiles.
Rapid technological modernisation is adding further pressure, making the overlap between industrial policy and antitrust law harder for regulators to ignore.
Section 857 of the Fiscal Year 2024 National Defense Authorization Act reflects this shift in how merger review is being conducted in Washington.
The provision requires certain parties making Hart-Scott-Rodino filings to also provide their materials to the Department of Defense when a transaction requires DOD review.
The Federal Trade Commission’s own premerger-notification page quotes Section 857 as applying to parties to a proposed merger or acquisition that “will require a review by the Department of Defense” and that are also required to file HSR materials with DOJ or the FTC.
Section 857 is more than a filing rule, carrying substantive implications for how defence priorities are weighed against competition analysis in complex transactions.
A merger that increases market concentration might still be defended on the grounds that it strengthens domestic supply chains or accelerates strategically important technology development.
The IonQ-SkyWater deal matters less as a standalone merger than as an example of how emerging-technology deals can raise competition, industrial-policy, and national-security issues simultaneously.
Section 857 may bring the DOD into merger review earlier, but its relevance will be clearest in deals involving defence contractors, strategic technologies, supply chains, or critical infrastructure.
National security should matter when a deal affects defence supply chains, military readiness, critical technologies, or domestic manufacturing, but these factors do not always align with traditional antitrust analysis.
The harder cases will be those in which national-security arguments support a deal that raises ordinary antitrust concerns, forcing agencies to explain whether they are applying competition law, industrial policy, or both.
Regulators face a growing burden of transparency as these overlapping frameworks collide, with little established precedent to guide decisions where defence imperatives and competition principles diverge sharply.